FZD9
Frizzled-9
Also known as: CD349, FZD3, FZD9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00144
- Gene
- FZD9
- Ensembl
- ENSG00000188763
- Chromosome
- 7
- Canonical length
- 591 aa
- Protein class
- CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins
OverviewNCBI Gene
Members of the 'frizzled' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins. The FZD9 gene is located within the Williams syndrome common deletion region of chromosome 7, and heterozygous deletion of the FZD9 gene may contribute to the Williams syndrome phenotype. FZD9 is expressed predominantly in brain, testis, eye, skeletal muscle, and kidney. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
591 residues, UniProt reviewed canonical sequence.
>O00144|FZD9
1 MAVAPLRGAL LLWQLLAAGG AALEIGRFDP ERGRGAAPCQ AVEIPMCRGI GYNLTRMPNL
61 LGHTSQGEAA AELAEFAPLV QYGCHSHLRF FLCSLYAPMC TDQVSTPIPA CRPMCEQARL
121 RCAPIMEQFN FGWPDSLDCA RLPTRNDPHA LCMEAPENAT AGPAEPHKGL GMLPVAPRPA
181 RPPGDLGPGA GGSGTCENPE KFQYVEKSRS CAPRCGPGVE VFWSRRDKDF ALVWMAVWSA
241 LCFFSTAFTV LTFLLEPHRF QYPERPIIFL SMCYNVYSLA FLIRAVAGAQ SVACDQEAGA
301 LYVIQEGLEN TGCTLVFLLL YYFGMASSLW WVVLTLTWFL AAGKKWGHEA IEAHGSYFHM
361 AAWGLPALKT IVILTLRKVA GDELTGLCYV ASTDAAALTG FVLVPLSGYL VLGSSFLLTG
421 FVALFHIRKI MKTGGTNTEK LEKLMVKIGV FSILYTVPAT CVIVCYVYER LNMDFWRLRA
481 TEQPCAAAAG PGGRRDCSLP GGSVPTVAVF MLKIFMSLVV GITSGVWVWS SKTFQTWQSL
541 CYRKIAAGRA RAKACRAPGS YGRGTHCHYK APTVVLHMTK TDPSLENPTH LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FZD9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 6.8 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 6.8 nTPM
- amygdala: 5.3 nTPM
- cerebral cortex: 4.6 nTPM
- hypothalamus: 4.6 nTPM
- testis: 4.4 nTPM
- midbrain: 4 nTPM
Single-cell type
- late spermatids: 21 nCPM
- paneth cells: 19 nCPM
- oligodendrocyte progenitor cells: 18 nCPM
- early spermatids: 9.6 nCPM
- lymphatic endothelial cells: 6.1 nCPM
- müller glia: 5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 9 nTPM
- medulla oblongata: 8.9 nTPM
- amygdala: 7.3 nTPM
- midbrain: 7.2 nTPM
- pons: 6.7 nTPM
- hypothalamus: 5.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.01
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- bone regeneration
- canonical Wnt signaling pathway
- learning or memory
- negative regulation of mitochondrial depolarization
- negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- negative regulation of necroptotic process
- negative regulation of neuron apoptotic process
- nervous system development
- neuroblast proliferation
- non-canonical Wnt signaling pathway
- ossification
- positive regulation of apoptotic process
- positive regulation of bone mineralization
- positive regulation of canonical Wnt signaling pathway
- positive regulation of neural precursor cell proliferation
- regulation of cell cycle
- regulation of cytosolic calcium ion concentration
- release of cytochrome c from mitochondria
- negative regulation of skeletal muscle acetylcholine-gated channel clustering
- regulation of skeletal muscle acetylcholine-gated channel clustering
Molecular functions
- G protein-coupled receptor activity
- protein heterodimerization activity
- protein homodimerization activity
- Wnt receptor activity
- Wnt-protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FZD9 as an antibody target. Whether an autoantibody or antibody against FZD9 could matter depends on whether native FZD9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FZD9 is annotated at the cell surface, where native FZD9 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FZD9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...